Time to Step Up and Fight Cancer in Africa
Health Policy Watch, Feb 4, 2023
In this op-ed published on World Cancer Day by Health Policy Watch, Wilfred Ngwa and Richard Marlink of Rutgers Global Health Institute write that cancer is threatening sub-Saharan African populations to a degree that demands a large-scale response.
White House Announcement on Cancer Moonshot Initiatives Highlights Botswana-Rutgers Partnership for Health
Rutgers Today, Dec 20, 2022
During the recent U.S.-Africa Leaders Summit, the White House’s Cancer Moonshot program highlighted several initiatives to drastically improve cancer outcomes in Africa. Two Botswana-Rutgers Partnership for Health efforts were featured.
Take a lesson from George W. Bush: Fund global COVID aid
Star-Ledger, Apr 14, 2022
A piece written by the Star-Ledger editorial board includes comments from Rutgers Global Health Institute director Richard Marlink about a model for global coronavirus aid that is similar to AIDS interventions in Africa and other regions.
Institute Honored by the American Repertory Ballet for Support During the Pandemic
Rutgers Global Health Institute, Mar 5, 2022
COVID-19 testing and vaccination clinics at the New Brunswick Performing Arts Center, where the ballet is a member company, are part of Rutgers Global Health Institute’s Equitable Recovery program. The clinics, which are open to the public, helped the ballet’s dancers safely return to the studio and stage.
Global vaccine equity: Calls rise to put principle into practice
Christian Science Monitor, Dec 3, 2021
Vaccine equity “is not just altruism but is critical for getting out of this pandemic,” Rutgers Global Health Institute director Richard Marlink told the Christian Science Monitor. The article describes how “domestic pressures and the impulse to take care of one’s own” have interfered with the success of COVAX, the international collaboration designed to ensure global access to COVID-19 vaccines.
What We Know About the Omicron Variant
Rutgers Today, Dec 1, 2021
With the first confirmed case of the Omicron coronavirus identified today in the United States and as the variant continues to spread around the world, Rutgers Today gathered perspectives from some of the university’s experts in infectious disease, epidemiology, pediatrics and global health. Richard Marlink, director of Rutgers Global Health Institute, is among these featured experts.
N.J.’s health system is failing underserved groups. How can the care divide be bridged?
NJ.com, Nov 20, 2021
A state-by-state scorecard of racial and ethnic disparities finds that all states’ health systems are failing people of color, according to a report released on November 18 by the Commonwealth Fund. Rutgers Global Health Institute director Richard Marlink discusses this report and the importance of addressing social determinants of health.
Better Together Event Explores Equitable Recovery
Rutgers Global Health Institute, Jun 30, 2021
Rutgers Global Health Institute and Rutgers University Alumni Association co-presented a virtual event about pandemic-related challenges minority communities are facing across the state, problems unique to underserved neighborhoods in Rutgers’ backyard, and what is needed to address these disparities. Institute director Richard Marlink led the discussion, which brought together university and community partners.
In Venezuela, politics overshadow COVAX shipment and vaccine rollout
Devex, Apr 15, 2021
Rutgers Global Health Institute director Richard Marlink discusses the COVAX (COVID-19 Vaccines Global Access) initiative and the need for a global response to the pandemic within the context of Venezuela’s efforts to obtain vaccines and release a vaccination plan amidst a power struggle between President Nicolás Maduro and opposition leader Juan Guaidó.
Rutgers professor discusses COVAX initiative, US involvement
The Daily Targum, Mar 8, 2021
Rutgers Global Health Institute director Richard Marlink discusses the COVID-19 Vaccines Global Access (COVAX) initiative to distribute vaccines more equitably worldwide. He says participation in COVAX is in the best interests of the U.S. and other wealthy countries due to the potential for virus variants to arise in countries where fewer people have received vaccines.
For more articles, click on the page numbers below…